[Puget Sound Business Journal] $1,000-a-pill hepatitis C drug may be too costly for Medicaid insurers

By Atia Musazay

May 14, 2014

A breakthrough drug now on the market could be a potential cure for hepatitis C. But with its costly price tag of $1,000, or $84,000 for a 12-week treatment, the state of Washington is concerned that not everyone who needs the medication will be able to afford it.

First Name*
Last Name*
Email*
CAPTCHA
FP1 Tracking: Basic Data
Origin URL Page Title Source URL Query String Date Time
FP1 Tracking: UTM Data
UTM Source UTM Medium UTM Campaign
FP1 Iterable: Lists
Lists
FP1 Iterable: Workflows
Workflows
Comments
This field is for validation purposes and should be left unchanged.

News & Updates

[Puget Sound Business Journal] $1,000-a-pill hepatitis C drug may be too costly for Medicaid insurers

By Atia Musazay

May 14, 2014

Sign-up for updates